Cibus(CBUS)

Search documents
Cibus ALERT: Cibus, Inc. Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
GlobeNewswire News Room· 2024-06-18 18:09
Core Viewpoint - Block & Leviton is investigating Cibus, Inc. for potential securities law violations following a report from Bonitas Research that raised concerns about the effectiveness of Cibus' gene-editing technology and its impact on crop yields [8]. Group 1: Investigation Details - Block & Leviton is looking into whether Cibus committed securities law violations and may file an action to recover losses for investors [5]. - Investors who have lost money in Cibus investments are encouraged to contact Block & Leviton for assistance [9]. - The investigation was prompted by allegations from Bonitas Research, which claimed that Cibus' technology does not deliver desirable new crops and highlighted farmer complaints regarding lower crop yields [8]. Group 2: Whistleblower Information - Individuals with non-public information about Cibus are encouraged to assist in the investigation or file a report with the SEC under the whistleblower program, potentially receiving rewards of up to 30% of any successful recovery [3]. Group 3: Company Background - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [7].
Cibus' Confirms Important Milestone for Nutrient Use Efficiency Trait Development
Newsfilter· 2024-06-17 11:00
Core Insights - Cibus has successfully edited its first Nutrient Use Efficiency (NUE) trait in Canola, marking a significant milestone in gene editing for major crops in North America [6][7] - The company aims to improve crop production efficiency by enhancing the absorption of soil-borne nutrients, thereby reducing fertilizer use without compromising yield [7][9] - Cibus utilizes its patented RTDS® technology platform, known as the Trait Machine™, to accelerate the development of complex traits compared to traditional breeding methods [4][8] Nutrient Use Efficiency (NUE) Development - The NUE trait is designed to enable lower fertilizer use while maintaining or improving expected crop yields, addressing the inefficiency of nitrogen absorption in plants [9] - Currently, only about one-third of applied nitrogen fertilizer is absorbed by plants, which limits biomass generation and grain yield [7] - The production of nitrogen fertilizer contributes to 3% of global CO2 emissions, and a 20% reduction in nitrogen fertilizer use could equate to removing 130 million cars from the road [7] Cibus' Technological Advancements - Cibus is a leader in next-generation gene-edited trait development, creating traits that are indistinguishable from those developed through traditional breeding [4] - The Trait Machine™ process allows for high-throughput gene editing, significantly changing the speed and scale of trait development [4][8] - The company has established a pipeline of advanced traits, including White Mold and HT2, alongside the newly developed NUE trait [2][8] Strategic Positioning and Partnerships - Through the merger with Calyxt, Cibus has solidified its position in gene editing and trait development for major crops, focusing on licensing traits to seed companies [8] - The company has developed multiple crop platforms, including Canola, Rice, and Wheat, and plans to complete its Soybean platform in 2024 [8] - Cibus emphasizes its capability to integrate third-party developed traits into its crop platforms, showcasing its versatility as a development partner [8]
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS
GlobeNewswire News Room· 2024-06-13 18:36
[Click here for information about joining the class action] Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for th ...
Cibus Announces $13.0 Million Registered Direct Offering
Newsfilter· 2024-06-12 12:00
Core Viewpoint - Cibus, Inc. has announced a registered direct offering of 1,298,040 shares of Class A Common Stock and warrants, aiming to raise approximately $13.0 million to fund the development of new seed traits and for general corporate purposes [1][6]. Group 1: Offering Details - The offering includes 1,298,040 shares of Class A Common Stock at a price of $10.00 per share for institutional investors and $10.20 for the CEO, Rory Riggs [1]. - The warrants are exercisable immediately at a price of $10.00 per share, with a different initial exercise price of $10.07 for Mr. Riggs, and will expire five years after issuance [1]. - The gross proceeds from the offering are expected to be approximately $13.0 million before deducting fees and expenses [6]. Group 2: Use of Proceeds - The net proceeds from the offering will be used to fund the development of new and existing seed traits, Trait Machine operations, and for working capital and general corporate purposes [6]. Group 3: Company Overview - Cibus is a leader in agricultural biotechnology, focusing on gene editing technologies to develop plant traits for major global crops such as canola, corn, rice, soybean, and wheat [8]. - The company is not a seed company but a technology company that licenses traits to seed companies in exchange for royalties [8]. - Cibus has developed a pipeline of five productivity traits, including Pod Shatter Reduction and Sclerotinia resistance, with some traits in commercial development with leading seed companies [8].
SHAREHOLDER ALERT: Cibus, Inc. Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
GlobeNewswire News Room· 2024-06-10 15:16
Core Viewpoint - Block & Leviton is investigating Cibus, Inc. for potential securities law violations following a report from Bonitas Research that raised concerns about the company's gene-editing technology and its impact on crop yields [5][9]. Group 1: Investigation Details - Block & Leviton is looking into allegations that Cibus' gene-editing technology does not deliver desirable new crops to market, with reports of farmer complaints regarding lower crop yields and lost revenues [5]. - The investigation is prompted by Bonitas Research's findings, which include examples of large seed manufacturers and distributors withdrawing from partnerships with Cibus [5]. Group 2: Investor Eligibility - Investors who have lost money on their Cibus investments may be eligible to participate in the investigation, regardless of whether they have sold their shares [6]. - Block & Leviton encourages affected investors to contact them for more information on potential recovery options [9]. Group 3: Whistleblower Information - Individuals with non-public information about Cibus are encouraged to assist in the investigation or report to the Securities Exchange Commission under the whistleblower program, which offers rewards of up to 30% of any successful recovery [3].
CIBUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cibus, Inc. on Behalf of Cibus Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2024-06-07 02:00
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cibus, Inc. ("Cibus" or the "Company") (NASDAQ: CBUS) on behalf of Cibus stockholders. Our investigation concerns whether Cibus has violated the federal securities laws and/or engaged in other unlawful business practices. On June 4, 2024, Bonitas Research published a report alleging, among other things, that "investors have been duped into be ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS
GlobeNewswire News Room· 2024-06-06 15:20
The investigation concerns whether Cibus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Toda ...
Investigation Into Cibus, Inc. (CBUS) Announced by Holzer & Holzer, LLC
Newsfilter· 2024-06-05 16:55
CONTACT: Corey Holzer, Esq. (888) 508-6832 (toll-free) cholzer@holzerlaw.com Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More informat ...
Investigation Into Cibus, Inc. (CBUS) Announced by Holzer & Holzer, LLC
GlobeNewswire News Room· 2024-06-05 16:55
Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website,www.holzerlaw.com, and up ...
Cibus to Participate in Upcoming June Investor Events
Newsfilter· 2024-06-05 11:00
Webcast link: https://wsw.com/webcast/stifel89/cbus/2099832 SAN DIEGO, June 05, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced its participation in the following June investor events. Stifel Cross Sector Insight Conference, Boston, MA - June 5, 2024: Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, will host a presentation beginning at 1:50 p.m. ET (10:50 a.m ...